Member Exclusive

Supporting the FDA’s tougher stance on unproven cell therapies: an interview with Massimo Dominici

In this interview, Massimo Dominici, ISCT past president, comments on the FDA’s recent statement on ‘unproven’ cell therapies.

Go to the profile of RegMedNet
Sep 06, 2017

Please sign in or register for FREE

No comments yet.